Status:
COMPLETED
The Effect of Covid-19 on the Disease Course of Multiple Sclerosis :Belgian Lessons Learned From Rocky I to Rocky IV
Lead Sponsor:
Marie D'hooghe
Conditions:
COVID-19
Eligibility:
All Genders
18-75 years
Brief Summary
Retrospective observational cohort study. ToFCoMS: two years of follow-up of COVID-19 in MS.
Detailed Description
Methods The Nationaal Multiple Sclerose Centrum (NMSC) Melsbroek is a large highly-specialized center specifically focusing on neurological management, multidisciplinary care and rehabilitation in pat...
Eligibility Criteria
Inclusion
- diagnosis of Multiple Sclerosis Covid 19 infection with PCR test
Exclusion
- other diagnosis than Multiple Sclerosis
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT05403463
Start Date
March 1 2022
End Date
June 1 2022
Last Update
June 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationaal MS center
Melsbroek, Vlaams Brabant, Belgium, 1820